VeriMomIst oligopeptide-106 in der Schwangerschaft sicher?
No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
Related ingredients
Frequently asked questions
- Ist oligopeptide-106 in der Schwangerschaft sicher?
- No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
- Ist oligopeptide-106 während des Stillens sicher?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no mechanistic evidence for transfer into breast milk or effects on lactation were identified. Given the lack of adverse signals and expected low dermal/systemic absorption of cosmetic peptides, risk is not indicated for breastfeeding (sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem).
- Ist oligopeptide-106 sicher für Babyhaut?
- No hazard or mechanistic data specific to infants were found. Adult dermal absorption is expected to be negligible for oligopeptides used in cosmetics (adult exposure scored 0), but because infant skin has a less mature barrier and higher surface‑area/weight, exposure scoring is increased by +1 to reflect potentially higher, low but measurable exposure in 0–3‑year‑olds. There is no infant‑specific toxicity evidence to increase hazard or mechanism scores (sources checked: CosIng, PubMed, ECHA Annex VI, PubChem).
- Wie bewertet VeriMom oligopeptide-106?
- VeriMom bewertet oligopeptide-106 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu oligopeptide-106?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu oligopeptide-106 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.